Valion Bio
VBIO
10 hedge funds and large institutions have $241K invested in Valion Bio in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
187% more capital invested
Capital invested by funds: $83.8K → $241K (+$157K)
100% more funds holding
Funds holding: 5 → 10 (+5)
0.32% more ownership
Funds ownership: 0.27% → 0.59% (+0.32%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCC
Cable Car Capital
San Francisco,
California
|
+$207K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$81K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$59.2K |
| 4 |
VF
Virtu Financial
New York
|
+$31.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$14 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCC
1
Cable Car Capital
San Francisco,
California
| $109K | +$207K | +16,471 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $42.6K | +$81K | +6,432 | New |
|
|
WAM
3
Warberg Asset Management
Winnetka,
Illinois
| $31.2K | +$59.2K | +4,706 | New |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $18.7K | – | – | – |
|
|
VF
5
Virtu Financial
New York
| $16K | +$31.1K | +2,470 | New |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $14.3K | +$17.8K | +1,410 | +185% |
|
7
Citadel Advisors
Miami,
Florida
| $5.63K | +$10.8K | +856 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $2.84K | +$843 | +67 | +19% |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $55 | – | – | – |
|
10
Bank of America
Charlotte,
North Carolina
| $25 | +$50 | +4 | New |
|
|
11
Wells Fargo
San Francisco,
California
| – | -$14 | -1 | Closed |
|
VBIO Hedge Fund Activity: Q2 2024 in Review
10 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Valion Bio (VBIO) for Q2 2024, worth a combined $241K — up 187% from $83.8K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new VBIO positions and 1 closed out — a net gain of 5 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Cable Car Capital, opening a new position worth an estimated $207K. The largest seller was Wells Fargo, exiting entirely with an estimated $14 sold.
- 10 institutional investors held Valion Bio (VBIO) as of Q2 2024, up from 5 in Q1 2024.
- Funds reported $241K of Valion Bio stock for Q2 2024, up 187% quarter-over-quarter.
- 6 funds opened new Valion Bio positions in Q2 2024 and 1 closed out, a net change of +5 holders.
- The largest Valion Bio buyer in Q2 2024 was Cable Car Capital, an estimated $207K added.
- The largest Valion Bio seller in Q2 2024 was Wells Fargo, an estimated $14 sold.
Based on aggregated 13F filings for Q2 2024.